Abiopharma

New Form 424B3 - Flora Growth Corp. <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0001062993-26-000441 <b>Size:</b> 11 KB

New Form SCHEDULE 13G - Repare Therapeutics Inc. <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0001723643-26-000001 <b>Size:</b> 10 KB

Global Affiliate Spotlight: SWE University of Lagos

New Form SCHEDULE 13D/A - BIODESIX INC <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0000905148-26-000363 <b>Size:</b> 11 KB

New Form SCHEDULE 13G - enGene Holdings Inc. <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0002005369-26-000002 <b>Size:</b> 25 KB

New Form D - NovaBay Pharmaceuticals, Inc. <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0001389545-26-000001 <b>Size:</b> 6 KB

New Form SCHEDULE 13G/A - LUNA INNOVATIONS INC <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0000906304-26-000034 <b>Size:</b> 10 KB

INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Ini

BD to Announce Financial Results for its First Quarter of Fiscal 2026

Waters - Waters Shareholders Approve Combination with BDs Biosciences & Diagnostic Solutions Business

CNS Pharmaceuticals - New Press Release

Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer

Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned

Propanc Biopharma Accelerates IP Momentum: Files Fourth Provisional Patent Application in Just Two Months – Strengthening Global Protection for Breakthrough Proenzyme Formulations

Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology